Past Presentations

IP Watchdog Webinar
December 1st, 2020
12:00-1:00PM ET

Drug Repositioning and Lifecycle Management: A Solid-Form Patent Strategy

The solid-state structure of an active pharmaceutical ingredient (API) can profoundly affect its properties.  Stability and solubility are functions of the solid-state structure of APIs.  This seminar will introduce the science behind such solid forms and then discuss how solid forms are protected as valuable intellectual property.  We will provide examples of how a solid-form patent strategy is integrated into life cycle management and drug repositioning, the nuts and bolts of obtaining such patents at the USPTO, and how the courts have viewed such patents over the past 15 years.  Although the focus will be on US practice, elements of European practice will also be presented.

NIPTE Research Conference
December 8th-11th 2020

Intellectual Property in Pharma: General Principles for the Research Scientist

More info coming soon

AAPS eChalk Talk
January 28th, 2021
11:00AM ET

Registration Info Coming Soon
Surveying the Exclusivity and Patent Status of Remdesivir

Remdesivir is the first approved therapy for COVID-19, having first received an Emergency Use Authorization and then finally full approval on October 22, 2020. As a fully approved drug, the FDA has provided the public with both regulatory exclusivity and patent information. In this presentation, we will review that information, discuss what it means, and relate that to typical strategies used by innovator companies to protect valuable assets.